Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Infectious Diseases |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000500434 |
Resumo: | Abstract Chronic hepatitis B is an important health problem that can progress to cirrhosis and complications such as hepatocellular carcinoma. There is approximately 290 million of people with chronic hepatitis B virus (HBV) infection worldwide, however only 10% of patients are currently identified.Most part of Brazil is considered of low prevalence of HBV infection but there are some regions with higher frequency of carriers. Unfortunately, many infected patients are not yet identified nor evaluated for treatment.The Brazilian Society of Infectious Diseases (SBI) and the Brazilian Society of Hepatology worked together to elaborate a guideline for diagnosis and treatment of hepatitis B. The document includes information regarding the population to be tested, diagnostic tools, indications of treatment, therapeutic schemes and also how to handle HBV infection in specific situations (pregnancy, children, immunosuppression, etc).Delta infection is also part of the guideline, since it is an important infection in some parts of the country. |
id |
BSID-1_8c57ea60231922106fcbf365402e7883 |
---|---|
oai_identifier_str |
oai:scielo:S1413-86702020000500434 |
network_acronym_str |
BSID-1 |
network_name_str |
Brazilian Journal of Infectious Diseases |
repository_id_str |
|
spelling |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis BHepatitis C antibodiesKidney transplantationLiver cirrhosisOutcome assessment (health care)Abstract Chronic hepatitis B is an important health problem that can progress to cirrhosis and complications such as hepatocellular carcinoma. There is approximately 290 million of people with chronic hepatitis B virus (HBV) infection worldwide, however only 10% of patients are currently identified.Most part of Brazil is considered of low prevalence of HBV infection but there are some regions with higher frequency of carriers. Unfortunately, many infected patients are not yet identified nor evaluated for treatment.The Brazilian Society of Infectious Diseases (SBI) and the Brazilian Society of Hepatology worked together to elaborate a guideline for diagnosis and treatment of hepatitis B. The document includes information regarding the population to be tested, diagnostic tools, indications of treatment, therapeutic schemes and also how to handle HBV infection in specific situations (pregnancy, children, immunosuppression, etc).Delta infection is also part of the guideline, since it is an important infection in some parts of the country.Brazilian Society of Infectious Diseases2020-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000500434Brazilian Journal of Infectious Diseases v.24 n.5 2020reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2020.07.012info:eu-repo/semantics/openAccessFerraz,Maria LuciaStrauss,EdnaPerez,Renata MelloSchiavon,LeonardoOno,Suzane KiokoPessoa,Mario GuimarãesFerreira,Adalgisa PaivaNabuco,LeticiaCarvalho-Filho,RobertoTovo,CristianeSouto,FranciscoAbrão,PauloReuter,TaniaDantas,ThorVigani,AlinePorta,GildaFerreira,Marcelo SimãoParaná,RaymundoCimerman,SergioBittencourt,Paulo Lisboaeng2020-11-26T00:00:00Zoai:scielo:S1413-86702020000500434Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2020-11-26T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false |
dc.title.none.fl_str_mv |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B |
title |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B |
spellingShingle |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B Ferraz,Maria Lucia Hepatitis C antibodies Kidney transplantation Liver cirrhosis Outcome assessment (health care) |
title_short |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B |
title_full |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B |
title_fullStr |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B |
title_full_unstemmed |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B |
title_sort |
Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B |
author |
Ferraz,Maria Lucia |
author_facet |
Ferraz,Maria Lucia Strauss,Edna Perez,Renata Mello Schiavon,Leonardo Ono,Suzane Kioko Pessoa,Mario Guimarães Ferreira,Adalgisa Paiva Nabuco,Leticia Carvalho-Filho,Roberto Tovo,Cristiane Souto,Francisco Abrão,Paulo Reuter,Tania Dantas,Thor Vigani,Aline Porta,Gilda Ferreira,Marcelo Simão Paraná,Raymundo Cimerman,Sergio Bittencourt,Paulo Lisboa |
author_role |
author |
author2 |
Strauss,Edna Perez,Renata Mello Schiavon,Leonardo Ono,Suzane Kioko Pessoa,Mario Guimarães Ferreira,Adalgisa Paiva Nabuco,Leticia Carvalho-Filho,Roberto Tovo,Cristiane Souto,Francisco Abrão,Paulo Reuter,Tania Dantas,Thor Vigani,Aline Porta,Gilda Ferreira,Marcelo Simão Paraná,Raymundo Cimerman,Sergio Bittencourt,Paulo Lisboa |
author2_role |
author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Ferraz,Maria Lucia Strauss,Edna Perez,Renata Mello Schiavon,Leonardo Ono,Suzane Kioko Pessoa,Mario Guimarães Ferreira,Adalgisa Paiva Nabuco,Leticia Carvalho-Filho,Roberto Tovo,Cristiane Souto,Francisco Abrão,Paulo Reuter,Tania Dantas,Thor Vigani,Aline Porta,Gilda Ferreira,Marcelo Simão Paraná,Raymundo Cimerman,Sergio Bittencourt,Paulo Lisboa |
dc.subject.por.fl_str_mv |
Hepatitis C antibodies Kidney transplantation Liver cirrhosis Outcome assessment (health care) |
topic |
Hepatitis C antibodies Kidney transplantation Liver cirrhosis Outcome assessment (health care) |
description |
Abstract Chronic hepatitis B is an important health problem that can progress to cirrhosis and complications such as hepatocellular carcinoma. There is approximately 290 million of people with chronic hepatitis B virus (HBV) infection worldwide, however only 10% of patients are currently identified.Most part of Brazil is considered of low prevalence of HBV infection but there are some regions with higher frequency of carriers. Unfortunately, many infected patients are not yet identified nor evaluated for treatment.The Brazilian Society of Infectious Diseases (SBI) and the Brazilian Society of Hepatology worked together to elaborate a guideline for diagnosis and treatment of hepatitis B. The document includes information regarding the population to be tested, diagnostic tools, indications of treatment, therapeutic schemes and also how to handle HBV infection in specific situations (pregnancy, children, immunosuppression, etc).Delta infection is also part of the guideline, since it is an important infection in some parts of the country. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000500434 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000500434 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjid.2020.07.012 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
dc.source.none.fl_str_mv |
Brazilian Journal of Infectious Diseases v.24 n.5 2020 reponame:Brazilian Journal of Infectious Diseases instname:Brazilian Society of Infectious Diseases (BSID) instacron:BSID |
instname_str |
Brazilian Society of Infectious Diseases (BSID) |
instacron_str |
BSID |
institution |
BSID |
reponame_str |
Brazilian Journal of Infectious Diseases |
collection |
Brazilian Journal of Infectious Diseases |
repository.name.fl_str_mv |
Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID) |
repository.mail.fl_str_mv |
bjid@bjid.org.br||lgoldani@ufrgs.br |
_version_ |
1754209245110206464 |